CNO Financial actuary sells 8,782 shares in plan

CNO’s Chief Actuary exercised stock options and sold 8,782 shares under a pre-arranged Rule 10b5-1 trading plan in mid-September 2026.

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) reported that Chief Actuary Jeremy D. Williams exercised employee stock options and sold the resulting common shares in mid-September 2026. On September 15 and 16, he exercised options for a total of 7,660 shares and sold 8,782 shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 7 txns

Insider Williams Jeremy D.

Role Chief Actuary

Sold 8,782 shs ($487K)

Approx. gross sale proceeds $487K

Approx. exercise cost $169K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy) F6	3,240	$0.00	$0.00
Exercise	Common Stock	3,240	$23.33	$76K
Sale	Common Stock F1, F3	3,240	$55.7138	$181K
Sale	Common Stock F1, F4	1,122	$55.7192	$63K
Exercise	Employee Stock Option (Right to Buy) F5	4,420	$0.00	$0.00
Exercise	Common Stock	4,420	$21.06	$93K
Sale	Common Stock F1, F2	4,420	$55.2696	$244K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 61,041 shares (Direct)

Footnotes (6)

1. F1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
2. F2. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.01 per share to $55.50 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
3. F3. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.84 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
4. F4. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.82 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
5. F5. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.
6. F6. One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021.

Key Figures

Shares sold: 8,782 shares Options exercised: 7,660 shares Exercise price September 15, 2026: $21.06 per share +4 more

7 metrics

Shares sold 8,782 shares Common stock sales reported for September 15–16, 2026

Options exercised 7,660 shares Employee stock options exercised in mid-September 2026

Exercise price September 15, 2026 $21.06 per share Employee stock options for 4,420 shares of common stock

Exercise price September 16, 2026 $23.33 per share Employee stock options for 3,240 shares of common stock

Weighted average sale price September 15, 2026 $55.2696 per share Sale of 4,420 shares of common stock

Weighted average sale price September 16, 2026 (larger block) $55.7138 per share Sale of 3,240 shares of common stock

Weighted average sale price September 16, 2026 (smaller block) $55.7192 per share Sale of 1,122 shares of common stock

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, vested and became exercisable

3 terms

Rule 10b5-1 trading plan regulatory

"Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Reflects the weighted average sale price."

vested and became exercisable financial

"One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CNO (CNO) disclose for Jeremy D. Williams in this Form 4?

The filing reports that Chief Actuary Jeremy D. Williams exercised employee stock options for 7,660 shares of CNO common stock and sold 8,782 shares of common stock in market transactions on September 15 and 16, 2026.

Were the CNO (CNO) insider stock sales by Jeremy D. Williams under a Rule 10b5-1 plan?

Yes. The sales of CNO common stock were made pursuant to a Rule 10b5-1 trading plan that was adopted on May 8, 2026, according to the footnotes describing the transactions.

How many CNO (CNO) options did Jeremy D. Williams exercise and at what exercise prices?

Jeremy D. Williams exercised employee stock options covering 4,420 shares at an exercise price of $21.06 per share on September 15, 2026, and 3,240 shares at an exercise price of $23.33 per share on September 16, 2026.

At what prices did Jeremy D. Williams sell CNO (CNO) common stock in these transactions?

He sold 4,420 shares at a weighted average price of about $55.27 on September 15, 2026, and on September 16, 2026 sold 3,240 shares at about $55.71 and 1,122 shares at about $55.72, with each price representing a weighted average within stated ranges.

What does the Form 4 say about the price ranges for the CNO (CNO) stock sales?

The filing states that the reported prices are weighted average sale prices. On September 15, 2026, shares were sold between $55.01 and $55.50. On September 16, 2026, shares were sold in ranges of $55.54 to $55.84 and $55.54 to $55.82, depending on the sale group.

What vesting information is provided for the CNO (CNO) stock options exercised by Jeremy D. Williams?

The filing notes that for one option grant, one-half vested and became exercisable on February 23, 2019 and one-half on February 23, 2020. For the other grant, one-half vested on February 21, 2020 and one-half on February 21, 2021.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 06:10 PM Accepted by SEC EDGAR 09/16/2026 - 06:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Jeremy D.

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Actuary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		M		4,420	A	$21.06	66,583	D
Common Stock	09/15/2026		S		4,420(1)	D	$55.2696(2)	62,163	D
Common Stock	09/16/2026		M		3,240	A	$23.33	65,403	D
Common Stock	09/16/2026		S		3,240(1)	D	$55.7138(3)	62,163	D
Common Stock	09/16/2026		S		1,122(1)	D	$55.7192(4)	61,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$21.06	09/15/2026		M			4,420	(5)	02/23/2027	Common Stock	4,420	$0	0	D
Employee Stock Option (Right to Buy)	$23.33	09/16/2026		M			3,240	(6)	02/21/2028	Common Stock	3,240	$0	0	D

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.

2. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.01 per share to $55.50 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.84 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

4. Reflects the weighted average sale price. Shares were sold at prices ranging from $55.54 per share to $55.82 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

5. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.

6. One-half of the stock options vested and became exercisable on February 21, 2020, and one-half vested and became exercisable on February 21, 2021.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)